Literature DB >> 30854739

Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.

Gauri Deb1,2, Eswar Shankar1, Vijay S Thakur1, Lee E Ponsky1,3, Donald R Bodner1,3, Pingfu Fu4,5, Sanjay Gupta1,3,6,5,7.   

Abstract

Green tea polyphenols (GTPs) and their major constituent, epigallocatechin-3-gallate (EGCG), have been reported to demonstrate many interesting biological activities, including anticancer properties. Recent studies on prostate cancer provide strong evidence that epigenetic mechanisms are major players in the regulation of matrix metalloproteinases (MMPs) and their binding partner tissue inhibitor of MMPs (TIMPs) involved in prostate cancer progression. Here we demonstrate that GTP/EGCG mediate epigenetic reactivation of TIMP-3 that plays a key role in suppressing invasiveness and cancer progression. Treatment of human prostate cancer DUPRO and LNCaP cells with 10 µg/mL GTP and 20 µM EGCG induced TIMP-3 mRNA and protein expression. This transcriptional activation of TIMP-3 was associated with the decrease in the expression of both enhancers of zeste homolog 2 (EZH2) and its catalytic product trimethylation of histone H3 at lysine 27 (H3K27me3) repressive marks at the TIMP-3 promoter with an accompanying increase in histone H3K9/18 acetylation. In addition, GTP/EGCG treatment significantly reduced class I histone deacetylase (HDAC) activity/expression and EZH2 and H3K27me3 levels in prostate cancer cells. EGCG/GTP exposure also reduced MMP-2/MMP-9 gelatinolytic activity and abrogated invasion and migration capabilities in these cells. Silencing of EZH2 and class I HDACs strikingly increased the expression of TIMP-3 independent of DNA methylation. Furthermore, clinical trials performed on patients undergoing prostatectomy consuming 800 mg EGCG (Polyphenon E) up to 6 weeks and grade-matched controls demonstrate an increase in plasma TIMP-3 levels. A marked reduction in class I HDACs activity/expression and EZH2 and H3K27me3 levels were noted in GTP-supplemented prostate tissue. Our findings highlight that TIMP-3 induction, as a key epigenetic event modulated by green tea in restoring the MMP:TIMP balance suppresses prostate cancer progression.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  enhancer of zeste homolog 2 (EZH2); green tea polyphenols (GTPs); histone deacetylases (HDAC); prostate cancer; tissue inhibitors of matrix metalloproteinase-3 (TIMP-3)

Mesh:

Substances:

Year:  2019        PMID: 30854739     DOI: 10.1002/mc.23003

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  16 in total

Review 1.  Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model.

Authors:  Rosa Divella; Antonella Daniele; Eufemia Savino; Angelo Paradiso
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

Review 2.  Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer.

Authors:  Sze Wan Hung; Yiran Li; Xiaoyan Chen; Kai On Chu; Yiwei Zhao; Yingyu Liu; Xi Guo; Gene Chi-Wai Man; Chi Chiu Wang
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

3.  Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer.

Authors:  Eswar Shankar; Mitali Pandey; Shiv Verma; Ata Abbas; Mario Candamo; Rajnee Kanwal; Sanjeev Shukla; Gregory T MacLennan; Sanjay Gupta
Journal:  Mol Carcinog       Date:  2020-05-11       Impact factor: 4.784

Review 4.  Tissue inhibitor of matrix metalloproteinase-3 has both anti-metastatic and anti-tumourigenic properties.

Authors:  Geetanjali P Rai; Sarah K Baird
Journal:  Clin Exp Metastasis       Date:  2020-01-01       Impact factor: 5.150

Review 5.  The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.

Authors:  Abdelhakim Bouyahya; Hamza Mechchate; Loubna Oumeslakht; Ikrame Zeouk; Sara Aboulaghras; Abdelaali Balahbib; Gokhan Zengin; Mohammad Amjad Kamal; Monica Gallo; Domenico Montesano; Nasreddine El Omari
Journal:  Biomolecules       Date:  2022-02-25

6.  Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.

Authors:  Oskar Ciesielski; Marta Biesiekierska; Aneta Balcerczyk
Journal:  Molecules       Date:  2020-05-16       Impact factor: 4.411

Review 7.  Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium.

Authors:  Marek Samec; Alena Liskova; Lenka Koklesova; Veronika Mestanova; Maria Franekova; Monika Kassayova; Bianka Bojkova; Sona Uramova; Pavol Zubor; Katarina Janikova; Jan Danko; Samson Mathews Samuel; Dietrich Büsselberg; Peter Kubatka
Journal:  Biomolecules       Date:  2019-12-05

Review 8.  Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention.

Authors:  Simona Izzo; Valeria Naponelli; Saverio Bettuzzi
Journal:  Nutrients       Date:  2020-04-06       Impact factor: 5.717

Review 9.  EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways.

Authors:  Ammad Ahmad Farooqi; Marina Pinheiro; Andreia Granja; Fulvia Farabegoli; Salette Reis; Rukset Attar; Uteuliyev Yerzhan Sabitaliyevich; Baojun Xu; Aamir Ahmad
Journal:  Cancers (Basel)       Date:  2020-04-12       Impact factor: 6.639

10.  Transient exposure to elevated glucose levels causes persistent changes in dermal microvascular endothelial cell responses to injury.

Authors:  Qiuyun Wang; Fei Song; Jiaoyun Dong; Liang Qiao
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.